You are here: Home » News-CM » Companies » News
Business Standard

Wockhardt receives USFDA approval for cancer drug Decitabine Injection

Capital Market 

has received approval from the Food & Drug Administration (US FDA) for an ANDA for 50mg of Decitabine, which is used to treat certain forms of Wockhardt's is a generic version of Dacogen, marketed in USA and other countries by Otsuka.

is used to treat (MDS), a group of in which immature blood cells in the bone marrow do not mature and therefore do not become healthy blood cells.

According to IQVIA February 2019 data, the product has sales of $120 million in the US.

will be launching this product in the United States, in a short period of time. With its nationwide and its excellent relationship with all major trade, retail and institutional customers, is already a significant

The product is being manufactured at a contract manufacturing facility, based near Hyderabad,

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, April 11 2019. 09:27 IST